Citation: L. Andrews et G. Friedland, Progress in hiv therapeutics and the challenges of adherence to antiretroviral therapy, INF DIS CL, 14(4), 2000, pp. 901
Authors:
Schooley, RT
Spino, C
Kuritzkes, D
Walker, BD
Valentine, FT
Hirsch, MS
Cooney, E
Friedland, G
Kundu, S
Merigan, TC
McElrath, MJ
Collier, A
Plaeger, S
Mitsuyasu, R
Kahn, J
Haslett, P
Uherova, P
deGruttola, V
Chiu, S
Zhang, B
Jones, G
Bell, D
Ketter, N
Twadell, T
Chernoff, D
Rosandich, M
Citation: Rt. Schooley et al., Two double-blinded, randomized, comparative trials of 4 human immunodeficiency virus type 1 (HIV-1) envelope vaccines in HIV-1-infected individuals across a spectrum of disease severity: AIDS clinical trials groups 209 and 214, J INFEC DIS, 182(5), 2000, pp. 1357-1364
Authors:
Lin, PF
Gonzalez, CJ
Griffith, B
Friedland, G
Calvez, V
Ferchal, F
Schinazi, RF
Shepp, DH
Ashraf, AB
Wainberg, MA
Soriano, V
Mellors, JW
Colonno, RJ
Citation: Pf. Lin et al., Stavudine resistance: an update on susceptibility following prolonged therapy, ANTIVIR TH, 4(1), 1999, pp. 21-28